Literature DB >> 3112223

A T cell-independent mechanism of macrophage activation by interferon-gamma.

G J Bancroft, R D Schreiber, G C Bosma, M J Bosma, E R Unanue.   

Abstract

A primary interest in immunity to intracellular pathogenic microorganisms and tumors is to understand the mechanisms by which macrophages are activated for various functions. Two parameters of macrophage activation are the expression of the class II histocompatibility proteins or Ia molecules (1), and cytotoxic activity. The ability of T cells to induce these responses has been extensively documented and occurs via their secretion of interferon-gamma (IFN-gamma) after interaction with antigen (2-6). However, in a recent study using mice with the severe combined immunodeficiency (scid) mutation (7) which have no detectable T or B cell functions (7-9), we were surprised to find the induction of Ia expression on macrophages and the partial inhibition of bacterial growth after infection with Listeria monocytogenes (10). We have now utilized neutralizing monoclonal antibodies specific for murine IFN-gamma to investigate the mechanism of macrophage activation in scid mice. We show here that IFN-gamma can be produced by scid mice in the absence of lymphocyte-mediated immunity, and this IFN-gamma is important for macrophage activation during infection with Listeria. These results indicate the presence of an important T lymphocyte-independent mechanism of macrophage activation and IFN-gamma production in response to infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112223

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  94 in total

1.  A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Authors:  Amy N Sieve; Karen D Meeks; Suheung Lee; Rance E Berg
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

2.  Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets.

Authors:  D Haller; S Blum; C Bode; W P Hammes; E J Schiffrin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Induction of anti-mycobacterial and anti-listerial activity of human monocytes requires different activation signals.

Authors:  G Zerlauth; M M Eibl; J W Mannhalter
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 4.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system.

Authors:  E Furrie; M W Turner; S Strobel
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection.

Authors:  C S Tripp; K P Beckerman; E R Unanue
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.

Authors:  M G Schwacha; J J Meissler; T K Eisenstein
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Authors:  Sara T Passos; Jonathan S Silver; Aisling C O'Hara; David Sehy; Jason S Stumhofer; Christopher A Hunter
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread.

Authors:  R A Barry; H G Bouwer; D A Portnoy; D J Hinrichs
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent.

Authors:  M J Scott; J J Hoth; M K Stagner; S A Gardner; J C Peyton; W G Cheadle
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.